Brain zaps for smokers: new trial tests quick quit method

NCT ID NCT07292883

Recruiting now Disease control Sponsor: Waypoint Centre for Mental Health Care Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 5-day course of accelerated deep transcranial magnetic stimulation (aTMS) can help adults aged 18–65 quit smoking. Participants receive 4 brain stimulation sessions per day for 5 days. The main goal is to see if the treatment is tolerable and practical, while also tracking smoking abstinence and cravings over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: accelerated deep transcranial magnetic stimulation (aTMS) using the H4 coil
What this could lead to: If successful, this could offer a fast, non-drug treatment to help people quit smoking by reducing cravings and supporting abstinence.
What could go wrong: This is a small early-phase trial (40 participants) focused on feasibility, not proof of effectiveness. The treatment requires multiple daily sessions, which may be hard to tolerate or complete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADDICTION NICOTINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior, Addictive nicotine dependence Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADDICTION NICOTINE TOBACCO USE DISORDER

Contacts and locations

Locations

Sunnybrook Health Sciences Centre
NOT_YET_RECRUITING

Toronto, Ontario, Canada
Waypoint Centre for Mental Health Care
RECRUITING

Penetanguishene, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.